Cutaneous lupus affects quality of life by limiting social participation and increasing mental health concerns, according to ...

In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...

Patient Chart Dynamix™ is an independent, data-driven service that unveils real-world patient management trends via large-scale patient chart audits. Designed to quantify practice patterns, measure ...

About Cutaneous Lupus Erythematosus CLE is a rare, chronic skin disease where IgG autoantibodies and immune complexes are observed to play a critical role in disease pathophysiology. CLE patients ...

Autoimmune diseases specialist Immunovant has announced changes to its leadership team and the expanded development of its ...

That means the future of Roivant is tied to the success, or otherwise, of Immunovant’s attempts to break into the FcRn market ...

inhibitor deucravacitinib has met the primary efficacy endpoints for the treatment of the skin manifestations of cutaneous lupus erythematosus (CLE). Unlike an earlier study, which was restricted ...

Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.

Immunovant has announced two new indications for IMVT-1402: Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE). When is the investor call to discuss Immunovant's updates?

EXTON, PA, April 10, 2025 (GLOBE NEWSWIRE) -- As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how ...